Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision history now lists a new Revision: v3.5.4, replacing the previous Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-18T03:28:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from version v3.5.2 to v3.5.3, indicating a minor platform/version update rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:16:20.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T12:46:33.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:31:17.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Updated the site revision tag from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:43:03.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2, with no visible changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:47:47.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.